Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant
Stopped The study was stopped during the interim analysis due to low accrual after the widespread use of plerixafor for multiple myeloma in the United States.
Conditions
- DS (Durie/Salmon) Stage I Plasma Cell Myeloma
- DS Stage II Plasma Cell Myeloma
- DS Stage III Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
Interventions
- DRUG: Desipramine Hydrochloride
- BIOLOGICAL: Filgrastim
- OTHER: Laboratory Biomarker Analysis
Sponsor
Albert Einstein College of Medicine
Collaborators